Exacerbating factors in neuroleptic malignant syndrome: comparisons between cases with death, sequelae, and full recovery.
Nagamine
Masanori
M
Yoshino
Aihide
A
Sakurai
Yutaka
Y
Sanga
Masaki
M
Takahashi
Ryuichi
R
Nomura
Soichiro
S
D000368:Aged; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001831:Body Temperature / Q000187:drug effects; D001971:Bromocriptine / Q000627:therapeutic use; D002423:Cause of Death; D003402:Creatine Kinase / Q000097:blood; D003620:Dantrolene / Q000627:therapeutic use; D018491:Dopamine Agonists / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007564:Japan / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D009125:Muscle Relaxants, Central / Q000627:therapeutic use; D009459:Neuroleptic Malignant Syndrome / Q000188:drug therapy / Q000453:epidemiology* / Q000401:mortality; D012189:Retrospective Studies; D012307:Risk Factors
D014150:Antipsychotic Agents; D018491:Dopamine Agonists; D009125:Muscle Relaxants, Central; D001971:Bromocriptine; D003402:Creatine Kinase; D003620:Dantrolene